KIBRA inhibitors belong to a class of chemical compounds specifically designed to target and modulate the activity or function of KIBRA (Kidney and Brain Expressed Protein). KIBRA is a protein involved in various cellular processes, including cell signaling, cell adhesion, and memory formation in the brain. It has been linked to the regulation of the Hippo signaling pathway, which plays a crucial role in controlling cell growth and organ size. The mechanisms of action of KIBRA inhibitors may involve various approaches, such as directly interacting with KIBRA to hinder its binding to other proteins or affecting its cellular functions. Alternatively, some inhibitors might target upstream regulators or downstream effectors of KIBRA, indirectly influencing its activity and cellular roles.
The study of KIBRA inhibitors has provided valuable insights into the molecular mechanisms underlying cellular processes and the significance of KIBRA in regulating cellular functions. By exploring KIBRA inhibitors, researchers aim to gain a better understanding of the complex cellular signaling networks involving KIBRA and its potential implications in cellular physiology. Continued research in this area may lead to further discoveries about KIBRA-related biology, contributing to advancements in scientific knowledge and potential applications in diverse research fields.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $354.00 $2764.00 | 5 | |
Verteporfin is a small molecule inhibitor of the Hippo signaling pathway, which indirectly affects KIBRA activity. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide is a natural compound that has been explored for its effects on the Hippo signaling pathway and KIBRA-related functions. | ||||||